![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/395 | (2006.01) |
C07K 16/28 | (2006.01) | ||
A61P 17/06 | (2006.01) |
(11) | Number of the document | 2523688 |
(13) | Kind of document | T |
(96) | European patent application number | 11705713.3 |
Date of filing the European patent application | 2011-01-12 | |
(97) | Date of publication of the European application | 2012-11-21 |
(45) | Date of publication and mention of the grant of the patent | 2017-10-11 |
(46) | Date of publication of the claims translation | 2018-03-12 |
(86) | Number | PCT/US2011/020985 |
Date | 2011-01-12 |
(87) | Number | WO 2011/088120 |
Date | 2011-07-21 |
(30) | Number | Date | Country code |
295387 P | 2010-01-15 | US | |
422059 P | 2010-12-10 | US |
(72) |
LIU, Dingjiang, US
HUANG, Holly Zhuohong, US
MARTIN, David Andrew, US
RUSSELL, Christopher Boyd, US
SALINGER, David H., US
BAUMGARTNER, Scott Walter, US
ENDRES, Christopher J., US
|
(73) |
Kirin-Amgen, Inc.,
One Amgen Center Drive, Thousand Oaks CA 91320-1799,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Antikūno kompozicija ir terapiniai režimai |
ANTIBODY FORMULATION AND THERAPEUTIC REGIMENS |
Payment date | Validity (years) | Amount | |
2025-01-06 | 15 | 289.00 EUR |
2026-01-12 |